Arvind Mathur is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on developing compounds that have the potential to treat various medical conditions, including viral infections and cancer.

Latest Patents

One of his latest patents involves substituted phenyl oxazolone compounds. This patent discloses compounds of Formula (I) or their stereoisomers, tautomers, or salts. Each R in the formula can independently be H or D. The patent also outlines methods for using these compounds to decrease the levels of IKZF1-4 proteins. These compounds are particularly useful in treating viral infections and proliferative disorders, such as cancer.

Another significant patent by Mathur details a process for the preparation of amino acids that are useful in creating peptide receptor modulators. This invention provides a process for preparing intermediates that can be used to synthesize amino acids. These amino acids are essential for developing peptide receptor modulators, including agonists or partial agonists of peptide receptors. Such modulators are beneficial for ameliorating diabetic conditions.

Career Highlights

Arvind Mathur is currently employed at Bristol-Myers Squibb Company, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments that address critical health issues.

Collaborations

Some of his notable coworkers include Philip Michael Sher and William N Washburn. Their collaboration has likely contributed to the success of various projects within the company.

Conclusion

Arvind Mathur's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through scientific advancements. His patents reflect a deep understanding of complex medical challenges and a dedication to finding effective solutions.

This text is generated by artificial intelligence and may not be accurate.